Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Development of Novel Anti-HIV Pyrimidobenzothiazine Derivatives - Tsukasa Mizuhara

Development of Novel Anti-HIV Pyrimidobenzothiazine Derivatives

Buch | Softcover
151 Seiten
2016 | Softcover reprint of the original 1st ed. 2013
Springer Verlag, Japan
978-4-431-56165-1 (ISBN)
CHF 109,95 inkl. MwSt
  • Versand in 10-15 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
The author successfully developed novel anti-HIV PD 404182 derivatives that exhibited submicromolar inhibitory activity against both HIV-1 and HIV-2. The second part explains SAR studies of PD 404182 for the development of anti-HIV agents.
The author successfully developed novel anti-HIV PD 404182 derivatives that exhibited submicromolar inhibitory activity against both HIV-1 and HIV-2. His thesis is in three parts. The first part expounds efficient methods for the synthesis of tricyclic heterocycles related to PD 404182 based on the sp2-carbon−heteroatom bond formations. Starting from arene or haloarene, C-O, C-N, or C-S bonds were formed by simply changing the reactants. These synthetic methods provide powerful approaches for the divergent preparation of pyrimido-benzoxazine, -quinazoline, or -benzothiazine derivatives. The second part explains SAR studies of PD 404182 for the development of anti-HIV agents. Through optimization studies of the central 1,3-thiazin-2-imine core, the benzene and cyclic amidine ring parts, 3-fold more potent inhibitors were obtained compared with the lead compound. The author also reveals by a time-of-drug-addition experiment that PD 404182 derivatives impaired HIV replication at the binding or fusion stage. The third part of the thesis elucidates the development of photoaffinity probes for the target identification of PD 404182. By the photolabeling experiment of HIV-1-infected H9 cells using these probes, the author detected proteins specifically bound to PD 404182. These new anti-HIV agents may be promising agents for anti-HIV therapy because their mechanisms of action differ from those of the currently approved anti-HIV agents.

Department of Chemistry University of Massachusetts Amherst, USA Ph. D. in Pharmaceutical Sciences Graduate School of Pharmaceutical Sciences, Kyoto University, Japan

Introduction.- Development of Divergent Synthetic Methods of Pyrimidobenzothiazine and Related Tricyclic Heterocycles.- Structure–Activity Relationship Study of PD 404182 Derivatives for the Highly Potent Anti-HIV Agents.- Design and Synthesis of Photoaffinity Probes and Their Application to Target Identification Study of PD 404182.- Conclusion.

Erscheinungsdatum
Reihe/Serie Springer Theses
Zusatzinfo 3 Illustrations, color; 95 Illustrations, black and white; XI, 151 p. 98 illus., 3 illus. in color.
Verlagsort Tokyo
Sprache englisch
Maße 155 x 235 mm
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Mikrobiologie / Infektologie / Reisemedizin
Medizin / Pharmazie Pharmazie
Naturwissenschaften Biologie Biochemie
Naturwissenschaften Biologie Mikrobiologie / Immunologie
Naturwissenschaften Chemie Organische Chemie
Technik
Schlagworte Anti-HIV Agents • Aromatic Nucleophilic Substitution • C−H Functionalization • PD 404182 • Photoaffinity Labeling • Pyrimidobenzothiazine • Structure−activity Relationship
ISBN-10 4-431-56165-X / 443156165X
ISBN-13 978-4-431-56165-1 / 9784431561651
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
und Erste Hilfe an Bord

von Jürgen Graf; Jochen Hinkelbein

Buch | Softcover (2024)
MWV Medizinisch Wissenschaftliche Verlagsgesellschaft
CHF 55,90